Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.24%.

  • Maravai Lifesciences Holdings' Return on Capital Employed fell 800.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.2% for FY2024, which is 1800.0% down from last year.
  • Maravai Lifesciences Holdings' Return on Capital Employed amounted to 0.24% in Q3 2025, which was down 800.0% from 0.37% recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Return on Capital Employed's 5-year high stood at 0.33% during Q1 2022, with a 5-year trough of 0.37% in Q2 2025.
  • Its 5-year average for Return on Capital Employed is 0.06%, with a median of 0.1% in 2023.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Return on Capital Employed surged by 1800bps in 2022, and later tumbled by -3300bps in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Return on Capital Employed (Quarter) stood at 0.31% in 2021, then decreased by -13bps to 0.27% in 2022, then crashed by -107bps to 0.02% in 2023, then plummeted by -1127bps to 0.22% in 2024, then decreased by -10bps to 0.24% in 2025.
  • Its Return on Capital Employed stands at 0.24% for Q3 2025, versus 0.37% for Q2 2025 and 0.29% for Q1 2025.